Skip To Main Content
Bartosz Wiernicki on Muck Rack

Bartosz Wiernicki

As seen in: Nature, MDPI
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Bartosz

Contact Bartosz, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Author Correction: Targeting ferroptosis protects against experimental (multi)organ dysfunction and death - Nature Communications

|
By Bartosz Wiernicki, Wulf Tonnus, Ruth Seurinck, Marcus Conrad, Andreas Linkermann, Peter Vandenabeele, Koen Augustyns
| Nature Verified
Correction to: Nature Communications https://doi.org/10.1038/s41467-022-28718-6, published online 24 February 2022 In the version of the article initially published, due to a calibration error, values for malondialdehyde (MDA) concentrations reported in the Results, Methods, Fig. 1 and Supp Figs. 1, 2 were underestimated by a factor of five.
Open in Who Shared Issue with article?

Molecular Mechanisms of Nemorosone-Induced Ferroptosis in Cancer Cells

|
By Behrouz Hassannia, Bartosz Wiernicki, Roberto Fernández-Acosta, Jurgen Caroen
| MDPI
Altmetric share Share announcement Help format_quote Cite thumb_up ... Endorse textsms ... Comment Need Help? Support Find support for a specific problem in the support section of our website. Get Support Feedback Please let us know what you think of our products and services. Give Feedback Information Visit our dedicated information section to learn more about MDPI.
Open in Who Shared Issue with article?

Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma

|
By Irina Ingold, Behrouz Hassannia, Bartosz Wiernicki, Feng Qu
| The Journal of Clinical Investigation
Antibodies and reagents. The following antibodies were used in this study: cleaved caspase-3 (Cell Signaling, 9661), β-tubulin (Abcam, ab21058), actin (MP Biomedicals, 69100), GPX4 (Abcam, ab41787), CD45 (BD Biosciences, 550539), Ki67 (Cell Signaling, 12202S), HMOX1 (Enzo Life Sciences, ADI-SPA-896-F), NRF2 (Abcam, ab62352), and KEAP1 (Proteintech, 10503-2-AP).
Open in Who Shared Issue with article?
See all 3 articles